NCT07283367 2025-12-15
A Phase Ib/II Trial of HS-20110 Combination Therapies in Advanced Colorectal Cancer Patients.
Hansoh BioMedical R&D Company
Phase 1/2 Not yet recruiting
Clinical Trials
6 trialsNCT07204574 2025-10-02
The Phase 1b/IIa, Open-label, Dose Escalation and Dose Expansion to Evaluate Safety, Tolerability, and Preliminary Efficacy of the Combination of HCB101, Cetuximab/Bevacizumab, and FOLFOX/FOLFIRI in Advanced or Metastatic Colorectal Cancer
Chang Gung Memorial Hospital
Phase 1/2 Recruiting
NCT04984369 2023-08-21
The Efficacy of HLX208 (BRAF V600E Inhibitor) With Cetuximab for Metastatic Colorectal Cancer (mCRC) With BRAF V600E Mutation After First-line Treatment
Shanghai Henlius Biotech
Phase 2 Unknown
NCT05239650 2022-05-03
Phase II Clinical Study to Evaluate the Efficacy and Safety of HLX07+HLX10 +mFOLFOX6 or HLX07 Monotherapy in Patients With mCRC
Shanghai Henlius Biotech
Phase 2 Not yet recruiting
NCT03337776 2021-08-05
Effect of WhatsApp Messenger on Uptake of CRC Screening Study
Chinese University of Hong Kong
Phase NA Withdrawn
NCT03601598 2018-07-26
A Trial of SHR-1210 in Combination With SHR6390 in Patients With Advanced CRC, NSCLC and HCC
Harbin Medical University
Phase 1/2 Unknown